16 results

517 New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
Kyuho Kim, Henry N. Ginsberg, Sung Hee Choi
KMSID: 1516079603   Diabetes Metab J. 2022;46(4):517-532.   Published online 2022 July 27    DOI: http://dx.doi.org/10.4093/dmj.2022.0198
533 Endoplasmic Reticulum Stress and Dysregulated Autophagy in Human Pancreatic Beta Cells
Seoil Moon, Hye Seung Jung
KMSID: 1516079597   Diabetes Metab J. 2022;46(4):533-542.   Published online 2022 July 27    DOI: http://dx.doi.org/10.4093/dmj.2022.0070
      
543 Renoprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors: Focusing on Renal Hemodynamics
Nam Hoon Kim, Nan Hee Kim
KMSID: 1516079602   Diabetes Metab J. 2022;46(4):543-551.   Published online 2022 July 27    DOI: http://dx.doi.org/10.4093/dmj.2022.0209
      
552 Current Trends of Big Data Research Using the Korean National Health Information Database
Mee Kyoung Kim, Kyungdo Han, Seung-Hwan Lee
KMSID: 1516079599   Diabetes Metab J. 2022;46(4):552-563.   Published online 2022 July 27    DOI: http://dx.doi.org/10.4093/dmj.2022.0193
      
564 Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
Eugene Han
KMSID: 1516079600   Diabetes Metab J. 2022;46(4):564-566.   Published online 2022 July 27    DOI: http://dx.doi.org/10.4093/dmj.2022.0203
      
567 Comparative Effects of Sodium-Glucose Cotransporter 2 Inhibitor and Thiazolidinedione Treatment on Risk of Stroke among Patients with Type 2 Diabetes Mellitus
Seung Eun Lee, Hyewon Nam, Han Seok Choi, Hoseob Kim, Dae-Sung Kyoung, Kyoung-Ah Kim
KMSID: 1516079578   Diabetes Metab J. 2022;46(4):567-577.   Published online 2022 February 8    DOI: http://dx.doi.org/10.4093/dmj.2021.0160
      
578 Reproductive Life Span and Severe Hypoglycemia Risk in Postmenopausal Women with Type 2 Diabetes Mellitus
Soyeon Kang, Yong-Moon Park, Dong Jin Kwon, Youn-Jee Chung, Jeong Namkung, Kyungdo Han, Seung-Hyun Ko
KMSID: 1516079581   Diabetes Metab J. 2022;46(4):578-591.   Published online 2022 January 24    DOI: http://dx.doi.org/10.4093/dmj.2021.0135
      
592 Effect of Low-Dose Persistent Organic Pollutants on Mitochondrial Function: Human and in Vitro Evidence
Se-A Kim, Hoyul Lee, Sung-Mi Park, Mi-Jin Kim, Yu-Mi Lee, Young-Ran Yoon, Hyun-Kyung Lee, Hyo-Bang Moon, In-Kyu Lee, Duk-Hee Lee
KMSID: 1516079577   Diabetes Metab J. 2022;46(4):592-604.   Published online 2022 January 26    DOI: http://dx.doi.org/10.4093/dmj.2021.0132
      
605 Effect of Different Types of Diagnostic Criteria for Gestational Diabetes Mellitus on Adverse Neonatal Outcomes: A Systematic Review, Meta-Analysis, and Meta-Regression
Fahimeh Ramezani Tehrani, Marzieh Saei Ghare Naz, Razieh Bidhendi-Yarandi, Samira Behboudi-Gandevani
KMSID: 1516079584   Diabetes Metab J. 2022;46(4):605-619.   Published online 2022 March 8    DOI: http://dx.doi.org/10.4093/dmj.2021.0178
      
620 Prevalence of Diabetic Retinopathy in Undiagnosed Diabetic Patients: A Nationwide Population-Based Study
Han Na Jang, Min Kyong Moon, Bo Kyung Koo
KMSID: 1516079576   Diabetes Metab J. 2022;46(4):620-629.   Published online 2022 February 23    DOI: http://dx.doi.org/10.4093/dmj.2021.0099
      
630 Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
Da Hea Seo, Young Ju Suh, Yongin Cho, Seong Hee Ahn, Seongha Seo, Seongbin Hong, Yong-ho Lee, Young Ju Choi, Eunjig Lee, So Hun Kim
KMSID: 1516079580   Diabetes Metab J. 2022;46(4):630-639.   Published online 2022 January 26    DOI: http://dx.doi.org/10.4093/dmj.2021.0130
      
640 Fatty Acid-Binding Protein 4 in Patients with and without Diabetic Retinopathy
Ping Huang, Xiaoqin Zhao, Yi Sun, Xinlei Wang, Rong Ouyang, Yanqiu Jiang, Xiaoquan Zhang, Renyue Hu, Zhuqi Tang, Yunjuan Gu
KMSID: 1516079586   Diabetes Metab J. 2022;46(4):640-649.   Published online 2022 April 28    DOI: http://dx.doi.org/10.4093/dmj.2021.0195
      
650 Development of Various Diabetes Prediction Models Using Machine Learning Techniques
Juyoung Shin, Jaewon Kim, Chanjung Lee, Joon Young Yoon, Seyeon Kim, Seungjae Song, Hun-Sung Kim
KMSID: 1516079579   Diabetes Metab J. 2022;46(4):650-657.   Published online 2022 March 11    DOI: http://dx.doi.org/10.4093/dmj.2021.0115
      
658 Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study
Hwi Seung Kim, Taekwan Yoon, Chang Hee Jung, Joong-Yeol Park, Woo Je Lee
KMSID: 1516079592   Diabetes Metab J. 2022;46(4):658-662.   Published online 2021 November 8    DOI: http://dx.doi.org/10.4093/dmj.2021.0232
      
663 Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658–62)
Tomoyuki Kawada
KMSID: 1516079598   Diabetes Metab J. 2022;46(4):663-664.   Published online 2022 July 27    DOI: http://dx.doi.org/10.4093/dmj.2022.0131
      [Original]
665 Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658–62)
Hwi Seung Kim, Woo Je Lee
KMSID: 1516079607   Diabetes Metab J. 2022;46(4):665-666.   Published online 2022 July 27    DOI: http://dx.doi.org/10.4093/dmj.2022.0166
      [Original]
Articles from Diabetes & Metabolism Journal are provided here courtesy of Korean Diabetes Association